CD8A and COVID-19: In addition, this study reported lower levels of IFN-γ in CD4+ T cells of COVID-19 patients with severe symptoms compared to those with mild symptoms, suggesting that the infection may initially downregulate CD4+ and CD8+ T-cells, thereby decreasing IFN-γ production.